Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs WOCKHARDT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA WOCKHARDT ASTRAZENECA PHARMA/
WOCKHARDT
 
P/E (TTM) x 95.5 -15.8 - View Chart
P/BV x 22.7 2.5 900.7% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 ASTRAZENECA PHARMA   WOCKHARDT
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-23
WOCKHARDT
Mar-23
ASTRAZENECA PHARMA/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs3,620316 1,147.3%   
Low Rs2,438145 1,677.2%   
Sales per share (Unadj.) Rs401.2184.0 218.1%  
Earnings per share (Unadj.) Rs39.7-43.1 -92.2%  
Cash flow per share (Unadj.) Rs46.2-25.7 -180.0%  
Dividends per share (Unadj.) Rs16.000-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs234.4231.7 101.2%  
Shares outstanding (eoy) m25.00144.09 17.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.51.3 602.8%   
Avg P/E ratio x76.3-5.3 -1,426.4%  
P/CF ratio (eoy) x65.5-9.0 -730.3%  
Price / Book Value ratio x12.91.0 1,298.8%  
Dividend payout %40.30-   
Avg Mkt Cap Rs m75,71833,202 228.1%   
No. of employees `000NANA-   
Total wages/salary Rs m2,5916,370 40.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,03026,510 37.8%  
Other income Rs m2611,220 21.4%   
Total revenues Rs m10,29127,730 37.1%   
Gross profit Rs m1,249-1,930 -64.7%  
Depreciation Rs m1632,510 6.5%   
Interest Rs m63,020 0.2%   
Profit before tax Rs m1,341-6,240 -21.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m348-30 -1,160.3%   
Profit after tax Rs m993-6,210 -16.0%  
Gross profit margin %12.5-7.3 -171.0%  
Effective tax rate %26.00.5 5,399.3%   
Net profit margin %9.9-23.4 -42.3%  
BALANCE SHEET DATA
Current assets Rs m9,35919,140 48.9%   
Current liabilities Rs m4,84434,350 14.1%   
Net working cap to sales %45.0-57.4 -78.5%  
Current ratio x1.90.6 346.8%  
Inventory Days Days4939 125.6%  
Debtors Days Days3911 356.6%  
Net fixed assets Rs m2,06148,670 4.2%   
Share capital Rs m50720 6.9%   
"Free" reserves Rs m5,81132,660 17.8%   
Net worth Rs m5,86133,380 17.6%   
Long term debt Rs m02,240 0.0%   
Total assets Rs m11,42170,750 16.1%  
Interest coverage x213.9-1.1 -20,057.4%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.90.4 234.4%   
Return on assets %8.7-4.5 -194.0%  
Return on equity %16.9-18.6 -91.1%  
Return on capital %23.0-9.0 -254.3%  
Exports to sales %00-   
Imports to sales %37.43.5 1,076.5%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m3,747920 407.3%   
Fx inflow Rs m612730 83.8%   
Fx outflow Rs m3,747920 407.3%   
Net fx Rs m-3,135-190 1,650.0%   
CASH FLOW
From Operations Rs m5831,530 38.1%  
From Investments Rs m181-1,250 -14.5%  
From Financial Activity Rs m-245-3,150 7.8%  
Net Cashflow Rs m519-2,800 -18.5%  

Share Holding

Indian Promoters % 0.0 54.9 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 5.4 4.5 121.0%  
FIIs % 2.7 4.2 63.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 45.1 55.5%  
Shareholders   29,032 161,813 17.9%  
Pledged promoter(s) holding % 0.0 74.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ASTRAZENECA PHARMA vs Wockhardt

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs Wockhardt Share Price Performance

Period ASTRAZENECA PHARMA Wockhardt S&P BSE HEALTHCARE
1-Day 0.01% 4.99% 1.18%
1-Month -3.61% 0.15% -0.75%
1-Year 59.20% 290.07% 61.82%
3-Year CAGR 20.50% 13.79% 18.16%
5-Year CAGR 22.18% 7.92% 19.79%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the Wockhardt share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of Wockhardt the stake stands at 54.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of Wockhardt.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 16.0 per share. This amounted to a Dividend Payout ratio of 40.3%.

Wockhardt paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of Wockhardt.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.